Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Jyh Ming Chow"'
Autor:
Szu-Yuan Wu, Yu-Ching Wen, Chia-Chi Ku, Yi-Chieh Yang, Jyh-Ming Chow, Shun-Fa Yang, Wei-Jiunn Lee, Ming-Hsien Chien
Publikováno v:
Journal of Biomedical Science, Vol 26, Iss 1, Pp 1-13 (2019)
Abstract Background Chemotherapy is the main treatment for acute myeloid leukemia (AML), but the cure rates for AML patients remain low, and the notorious adverse effects of chemotherapeutic drugs drastically reduce the life quality of patients. Penf
Externí odkaz:
https://doaj.org/article/fc6395cee53741559cdc011df43b2580
Autor:
Yu-Mei Zheng, Jyh-Ming Chow, Chia-Lun Chang, Liang-Hsiao Chao, Jacqueline Whang-Peng, Gi-Ming Lai
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 1185-1188 (2019)
Externí odkaz:
https://doaj.org/article/440188ced13c41b5aa10439ad239c2ae
Autor:
Jer-Hwa Chang, Chao-Wen Cheng, Yi-Chieh Yang, Wan-Shen Chen, Wen-Yueh Hung, Jyh-Ming Chow, Pai-Sheng Chen, Michael Hsiao, Wei-Jiunn Lee, Ming-Hsien Chien
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-16 (2018)
Abstract Background Metastasis rather than the primary cancer determines the survival of cancer patients. Activation of Akt plays a critical role in the epithelial-to-mesenchymal transition (EMT), the initial step in lung cancer metastasis. Apigenin
Externí odkaz:
https://doaj.org/article/9b30ba857f0d4aaa94401846f26c4a42
Autor:
I-Chun Lai, Gi-Ming Lai, Jyh-Ming Chow, Hsin-Lun Lee, Chuan-Feng Yeh, Chi-Han Li, Jiann-Long Yan, Shuang-En Chuang, Jacqueline Whang-Peng, Kuan-Jen Bai, Chih-Jung Yao
Publikováno v:
Chinese Medicine, Vol 12, Iss 1, Pp 1-12 (2017)
Abstract Background The non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. In NSCLC, the oncogenic AKT-mTOR, ERK and STAT3 pathways are commonly dysregulated and have emerged as attractive targets for therapeutic devel
Externí odkaz:
https://doaj.org/article/f5172744eba54cd9abf929dcd51a231e
Autor:
Chih-Jung Yao, Jyh-Ming Chow, Shuang-En Chuang, Chia-Lun Chang, Ming-De Yan, Hsin-Lun Lee, I-Chun Lai, Pei-Chun Lin, Gi-Ming Lai
Publikováno v:
Journal of Ginseng Research, Vol 41, Iss 3, Pp 247-256 (2017)
Background: KG-135, a standardized formulation enriched with Rk1, Rg3, and Rg5 ginsenosides, has been shown to inhibit various types of cancer cells; however, the underlying mechanisms are not fully understood. In this study, we explored its effects
Externí odkaz:
https://doaj.org/article/afa8f43ee80c42b08525b6a78dd94978
Autor:
Min-Liang Kuo, Kuo-Tai Hua, Michael Hsiao, Yi-Hua Jan, Jyh-Ming Chow, Jin-Shing Chen, Ming-Yang Wang, Tsu-Yao Cheng, Chia-Feng Li, Feng-Koo Hsieh, Wei-Jiunn Lee, Ming-Hsien Chien
Supplementary Figures 1-8. Supplementary Figure 1: Stably expressing Keap1 by CL1-5 cells is accompanied by decreasing migratory and invasive abilities. Supplementary Figure 2: Manipulation of Keap1 expression (overexpression or knockdown) had no sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::513eae2f46384314b378eeee48ccd839
https://doi.org/10.1158/1078-0432.22461549.v1
https://doi.org/10.1158/1078-0432.22461549.v1
Autor:
Min-Liang Kuo, Kuo-Tai Hua, Michael Hsiao, Yi-Hua Jan, Jyh-Ming Chow, Jin-Shing Chen, Ming-Yang Wang, Tsu-Yao Cheng, Chia-Feng Li, Feng-Koo Hsieh, Wei-Jiunn Lee, Ming-Hsien Chien
Purpose: Kelch-like ECH-associated protein 1 (Keap1) is an E3 ligase participated in the cellular defense response against oxidative stress through nuclear factor erythroid-2–related factor 2 (Nrf2). However, the role of Keap1 in regulating cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0930b8a5be54c84a9e1529597792d727
https://doi.org/10.1158/1078-0432.c.6524817
https://doi.org/10.1158/1078-0432.c.6524817
Autor:
Min-Liang Kuo, Kuo-Tai Hua, Michael Hsiao, Yi-Hua Jan, Jyh-Ming Chow, Jin-Shing Chen, Ming-Yang Wang, Tsu-Yao Cheng, Chia-Feng Li, Feng-Koo Hsieh, Wei-Jiunn Lee, Ming-Hsien Chien
Supplementary Tables 1-3. Supplementary Table 1: Clinicopathologic characteristics of patients with associated expression of Keap1 protein in NSCLC. Supplementary Table 2: Correlation between levels of Keap1 and Nrf2 expression in lung cancer. Supple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcf618ba7f9cf52885878a0d64a6170
https://doi.org/10.1158/1078-0432.22461546
https://doi.org/10.1158/1078-0432.22461546
Autor:
Min-Liang Kuo, Kuo-Tai Hua, Michael Hsiao, Yi-Hua Jan, Jyh-Ming Chow, Jin-Shing Chen, Ming-Yang Wang, Tsu-Yao Cheng, Chia-Feng Li, Feng-Koo Hsieh, Wei-Jiunn Lee, Ming-Hsien Chien
Supplementary Figure legends (Figures 1-8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d22745371a66e733d6f8e9d1e1f15a1
https://doi.org/10.1158/1078-0432.22461552
https://doi.org/10.1158/1078-0432.22461552
Autor:
Siew-Tzuh Tang, Tsang-Wu Liu, Jyh-Ming Chow, Chang-Fang Chiu, Chiun Hsu, Li-Ni Liu, Su-Ching Kuo
Publikováno v:
Journal of Cancer Research and Practice, Vol 2, Iss 3, Pp 195-204 (2015)
Background: Studies on age-related differences in preferences for end-of-life (EOL) care have generally concluded that increasing age predisposes patients to prefer less aggressive EOL care. However, these studies seldom are adjusted for healthcare n
Externí odkaz:
https://doaj.org/article/c3ff7e3f38964e99a7667a3d390e1dfe